Press Releases

6972 Press Releases
DateTitleCompany
17 Mar 10 Cardiocore Senior Scientist Presents Cardiac Safety for Diabetes Data at ACC.10 Cardiocore,
Published by
Cardiocoreo
17 Mar 10 Prosensa Strengthens its Management Team Prosensa ,
Published by
PharmiWeb.com
17 Mar 10 Idera Pharmaceuticals Announces Acceptance of IMO-2125 Abstracts for Presentation at EASL Annual Meeting Idera Pharmaceuticals,
Published by
Business Wire
17 Mar 10 Impax Laboratories to Present at the Barclays Capital 2010 Global Healthcare Conference Impax Laboratories Inc.,
Published by
Business Wire
17 Mar 10 Teva Provides Update on Generic Temodar® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Mar 10 First Installment of Calypso System in the United Kingdom at the Royal Marsden Hospital Calypso Medical Technologies Inc.,
Published by
Business Wire
17 Mar 10 NPS Pharmaceuticals to Present at Barclays Capital Global Healthcare Conference NPS Pharmaceuticals Inc.,
Published by
Business Wire
17 Mar 10 CNS Network Selects ALPHADAS®, Logos Technologies Early Phase EDC System Logos Technologies Inc,
Published by
Business Wire
17 Mar 10 Unigene Receives Additional Capital in Debt Restructuring; Begins to Revamp Management Team Unigene Laboratories Inc.,
Published by
Business Wire
17 Mar 10 Study Shows Prevenar 13* Is Immunogenic In Young Children Previously Vaccinated With Prevenar* Pfizer Inc.,
Published by
Business Wire
17 Mar 10 Regulus Announces U.S. Allowance of Stanford Patent Application Covering miR-181a Function in Immune Cells Regulus Therapeutics Inc.,
Published by
Business Wire
17 Mar 10 ABRAXANE Meets Primary Endpoint in Phase 3 Trial for Advanced Non-Small Cell Lung Cancer Abraxis BioScience Inc.,
Published by
Business Wire
17 Mar 10 HST Global, Inc. Nears Completion of Debt Financing to Fund Wellness Center Acquisition HST Global Inc.,
Published by
Business Wire
17 Mar 10 ImmunoCellular Therapeutics Receives Allowance of a New Patent on its Antibodies Targeting Pancreatic Cancer ImmunoCellular Therapeutics Ltd.,
Published by
Business Wire
17 Mar 10 MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx® Promotion for MOXATAG® MiddleBrook Pharmaceuticals Inc.,
Published by
Business Wire
17 Mar 10 Acucela and Otsuka Pharmaceutical Receive FDA Fast Track Designation for ACU-4429 in Patients with Dry AMD Acucela Inc.,
Published by
Business Wire
17 Mar 10 NexMed Bolsters Its Cash Reserve with $1.4 Million Infusion from Successful Mortgage Refinancing on Its New Jersey Facility NexMed Inc.,
Published by
Business Wire
17 Mar 10 New Research Identifies UBC as the Leader in Late Phase Service Quality Industry Standard Research,
Published by
Business Wire
17 Mar 10 Health Discovery Corporation and Smart Personalized Medicine Form Agreement for Developing Laboratory Tests for Breast Cancer Therapy Selection with Quest Diagnostics Health Discovery Corporation Smart Personalized Medicine LLC and Quest Diagnostics Incorporated,
Published by
Business Wire
17 Mar 10 CytoDyn Begins Full Humanization of Cytolin® CytoDyn Inc.,
Published by
Business Wire
17 Mar 10 Mannatech Vigorously Defends Ambrotose® Product Patents With Latest Legal Action Against Multiple Companies Mannatech Incorporated,
Published by
Business Wire
17 Mar 10 Targacept to Present at Barclays Capital 2010 Global Healthcare Conference Targacept Inc.,
Published by
Business Wire
17 Mar 10 Subretinal Implant Restores Unprecedented Level of Vision to Blind Patients Retina Implant AG,
Published by
Business Wire
17 Mar 10 Emisphere Announces Fourth Quarter/Year End 2009 Earnings Call Emisphere Technologies Inc.,
Published by
Business Wire
17 Mar 10 Medtronic Receives FDA Approval for Industry's Most Advanced Integrated System for Diabetes Management Medtronic Inc.,
Published by
Business Wire
17 Mar 10 Alkermes Announces Initiation of Multidose Phase 1 Clinical Study of ALKS 37 for the Treatment of Opioid-Induced Constipation Alkermes Inc.,
Published by
Business Wire
17 Mar 10 CDISC Selects Nextrials as a Registered Solutions Provider Nextrials Inc.,
Published by
Business Wire
17 Mar 10 APCER Pharma Signs Six Global Pharmaceutical Customers for Outsourced Pharmacovigilance Services; Expands U.S., Asia and European Operations APCER PHARMA,
Published by
Business Wire
17 Mar 10 U.S. Food And Drug Administration Accepts New Drug Application For Once-Daily Fixed Dose Combination Of Onglyzaâ„¢ (Saxagliptin) And Extended Release Metformin For The Treatment Of Type 2 Diabetes Mellitus In Adults Bristol-Myers Squibb Company,
Published by
Business Wire
17 Mar 10 Medtronic Announces Next-Generation Pacing System for Use in MRI Machines Now Commercially Available in Selected European Geographies Medtronic Inc.,
Published by
Business Wire
Advertising